GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NuVasive Inc (NAS:NUVA) » Definitions » Price-to-Operating-Cash-Flow

NuVasive (NuVasive) Price-to-Operating-Cash-Flow : 16.42 (As of Apr. 26, 2024)


View and export this data going back to 2004. Start your Free Trial

What is NuVasive Price-to-Operating-Cash-Flow?

As of today (2024-04-26), NuVasive's share price is $39.75. NuVasive's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $2.42. Hence, NuVasive's Price-to-Operating-Cash-Flow Ratio for today is 16.42.

The historical rank and industry rank for NuVasive's Price-to-Operating-Cash-Flow or its related term are showing as below:

NUVA' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 13.3   Med: 18.14   Max: 23.32
Current: 23.32

During the past 13 years, NuVasive's highest Price-to-Operating-Cash-Flow Ratio was 23.32. The lowest was 13.30. And the median was 18.14.

NUVA's Price-to-Operating-Cash-Flow is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 21.02 vs NUVA: 23.32

NuVasive's Cash Flow from Operations per share for the three months ended in Jun. 2023 was $0.69. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 was $2.42.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of NuVasive was -30.20% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -11.90% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -2.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 10.20% per year.

During the past 13 years, NuVasive's highest 3-Year average Operating Cash Flow per Share Growth Rate was 66.60% per year. The lowest was -11.90% per year. And the median was 19.60% per year.


NuVasive Price-to-Operating-Cash-Flow Historical Data

The historical data trend for NuVasive's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NuVasive Price-to-Operating-Cash-Flow Chart

NuVasive Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.84 17.47 14.02 17.61 18.66

NuVasive Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.07 17.44 18.66 18.59 23.32

Competitive Comparison of NuVasive's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, NuVasive's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NuVasive's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NuVasive's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where NuVasive's Price-to-Operating-Cash-Flow falls into.



NuVasive Price-to-Operating-Cash-Flow Calculation

NuVasive's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=39.75/2.421
=16.42

NuVasive's Share Price of today is $39.75.
NuVasive's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.42.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

NuVasive Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of NuVasive's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


NuVasive (NuVasive) Business Description

Traded in Other Exchanges
N/A
Address
12101 Airport Way, Broomfield, CO, USA, 92121
NuVasive Inc is a medical technology company focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, advance care and change lives. The company has a portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. It also develop and sell magnetically adjustable implant systems for spine and specialized orthopedic procedures.
Executives
Michael Farrington officer: SVP, People and Culture 7475 LUSK BLVD., SAN DIEGO CA 92121
Marc W. Rosenbaum officer: Chief Accounting Officer 7475 LUSK BLVD., SAN DIEGO CA 92121
James Christopher Barry director, officer: Chief Executive Officer 7475 LUSK BLVD, SAN DIEGO CA 92121
Andrew C. Morton officer: SVP, CHRO 10910 DOMAIN DRIVE, SUITE 300, AUSTIN TX 78758
Amy Belt Raimundo director ONE KAISER PLAZA, 22ND FLOOR, OAKLAND CA 94612
Lucas Vitale officer: Chief Human Resources Officer 7475 LUSK BLVD, SAN DIEGO CA 92121
Massimo Calafiore officer: EVP, Global Business Units 7475 LUSK BLVD., SAN DIEGO CA 92121
Siddhartha Kadia director 7475 LUSK BOULEVARD, SAN DIEGO CA 92121
Vickie L Capps director 2985 SCOTT STREET, VISTA CA 92083
Brent J. Boucher officer: EVP, Global Commercial 14 PLAZA DRIVE, LATHAM NY 12110
Matthew Link officer: Exec. VP U.S. Sales 7475 LUSK BLVD, SAN DIEGO CA 92121
Matthew K Harbaugh officer: EVP and CFO 675 MCDONNELL BLVD., HAZELWOOD MO 63042
Dale A. Wolf officer: SVP, Global Operations 7475 LUSK BLVD., SAN DIEGO CA 92121
Gregory T Lucier director C/O DENTSPLY SIRONA INC, 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC 28277
Paul Mcclintock officer: President, U.S. Commercial 7475 LUSK BLVD, SAN DIEGO CA 92121